CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Chicago
Lyell Immunopharma, Inc.
Essen Biotech
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Artiva Biotherapeutics, Inc.
Indapta Therapeutics, INC.
Chinese PLA General Hospital
Instituto Nacional de Cancer, Brazil
ImmunityBio, Inc.
Celgene
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Chinese PLA General Hospital
University Hospital Southampton NHS Foundation Trust
M.D. Anderson Cancer Center
TCR2 Therapeutics
Genentech, Inc.
Precision BioSciences, Inc.
M.D. Anderson Cancer Center
City of Hope Medical Center
GC Cell Corporation
Hoffmann-La Roche
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jichi Medical University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Kentucky
Northwestern University
Auxilio Mutuo Cancer Center
Maisonneuve-Rosemont Hospital